within Pharmacolibrary.Drugs.ATC.B;

model B05XA09
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 1.6666666666666667,
    adminDuration  = 600,
    adminMass      = 0.045,
    adminCount     = 1,
    Vd             = 0.0003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.005,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Sodium phosphate is an inorganic phosphate salt used primarily as a laxative and bowel cleanser prior to colonoscopy and other medical procedures. It acts as an osmotic agent, drawing water into the intestines to induce bowel movement. Sodium phosphate is approved for use in many countries but oral formulations have some safety warnings due to risk of acute phosphate nephropathy.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters in healthy adults, as published human PK data for sodium phosphate is scarce. Estimates below are based on typical properties of inorganic phosphate pharmacokinetics.</p><h4>References</h4><ol><li><p>Thomas, L, et al., &amp; Rieg, T (2019). Contribution of NHE3 and dietary phosphate to lithium pharmacokinetics. <i>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</i> 128 1–7. DOI:<a href=&quot;https://doi.org/10.1016/j.ejps.2018.11.008&quot;>10.1016/j.ejps.2018.11.008</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30419292/&quot;>https://pubmed.ncbi.nlm.nih.gov/30419292</a></p></li><li><p>Wang, X, et al., &amp; Wetterau, JR (2022). Effects of pharmacological inhibition of the sodium-dependent phosphate cotransporter 2b (NPT2b) on intestinal phosphate absorption in mouse and rat models. <i>Pharmacology research &amp; perspectives</i> 10(2) e00938–None. DOI:<a href=&quot;https://doi.org/10.1002/prp2.938&quot;>10.1002/prp2.938</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35194979/&quot;>https://pubmed.ncbi.nlm.nih.gov/35194979</a></p></li><li><p> (2019). Plenvu - a low-volume PEG-based colonoscopy preparation. <i>The Medical letter on drugs and therapeutics</i> 61(1564) 11–14. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30856159/&quot;>https://pubmed.ncbi.nlm.nih.gov/30856159</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end B05XA09;
